NCT03648372 2024-11-19A Study of TAK-981 in People With Advanced Solid Tumors or Cancers in the Immune SystemTakedaPhase 1/2 Terminated109 enrolled 54 charts
NCT04074330 2024-06-14A Study of TAK-981 Given With Rituximab in Adults With Relapsed or Refractory CD20-Positive Non-Hodgkin LymphomaTakedaPhase 1/2 Terminated38 enrolled 44 charts